Literature DB >> 15762817

Benzodiazepine use, abuse, and dependence.

Charles P O'brien1.   

Abstract

Although benzodiazepines are invaluable in the treatment of anxiety disorders, they have some potential for abuse and may cause dependence or addiction. It is important to distinguish between addiction to and normal physical dependence on benzodiazepines. Intentional abusers of benzodiazepines usually have other substance abuse problems. Benzodiazepines are usually a secondary drug of abuse-used mainly to augment the high received from another drug or to offset the adverse effects of other drugs. Few cases of addiction arise from legitimate use of benzodiazepines. Pharmacologic dependence, a predictable and natural adaptation of a body system long accustomed to the presence of a drug, may occur in patients taking therapeutic doses of benzodiazepines. However, this dependence, which generally manifests itself in withdrawal symptoms upon the abrupt discontinuation of the medication, may be controlled and ended through dose tapering, medication switching, and/or medication augmentation. Due to the chronic nature of anxiety, long-term low-dose benzodiazepine treatment may be necessary for some patients; this continuation of treatment should not be considered abuse or addiction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15762817

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  91 in total

1.  Model-based meta-analysis of the effects of non-selective and α1-selective GABAA receptor agonists in healthy volunteers.

Authors:  Yu-Peng Ren; Ru-Jia Xie; Scott Marshall; Liang Li; Tian-Yan Zhou; Wei Lu
Journal:  Eur J Clin Pharmacol       Date:  2015-08-11       Impact factor: 2.953

Review 2.  Treatment of Post-Traumatic Stress Disorders with the Alpha-1 Adrenergic Antagonist Prazosin.

Authors:  Philippe Yves Rémy Simon; Pierre-François Rousseau
Journal:  Can J Psychiatry       Date:  2016-07-19       Impact factor: 4.356

Review 3.  Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery.

Authors:  Mohammad S Alavijeh; Mansoor Chishty; M Zeeshan Qaiser; Alan M Palmer
Journal:  NeuroRx       Date:  2005-10

Review 4.  Neuropsychiatric effects of prescription drug abuse.

Authors:  Jason P Caplan; Lucy A Epstein; Davin K Quinn; Jonathan R Stevens; Theodore A Stern
Journal:  Neuropsychol Rev       Date:  2007-08-16       Impact factor: 7.444

Review 5.  Pharmacological strategies for detoxification.

Authors:  Alison M Diaper; Fergus D Law; Jan K Melichar
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

6.  Motivations for prescription drug misuse among young men who have sex with men (YMSM) in Philadelphia.

Authors:  Aleksandar Kecojevic; Heather L Corliss; Stephen E Lankenau
Journal:  Int J Drug Policy       Date:  2015-04-07

7.  Neural basis of benzodiazepine reward: requirement for α2 containing GABAA receptors in the nucleus accumbens.

Authors:  Elif Engin; Konstantin I Bakhurin; Kiersten S Smith; Rochelle M Hines; Lauren M Reynolds; Wannan Tang; Rolf Sprengel; Stephen J Moss; Uwe Rudolph
Journal:  Neuropsychopharmacology       Date:  2014-02-19       Impact factor: 7.853

Review 8.  Progress in neuroprotective strategies for preventing epilepsy.

Authors:  Munjal M Acharya; Bharathi Hattiangady; Ashok K Shetty
Journal:  Prog Neurobiol       Date:  2007-12-08       Impact factor: 11.685

9.  Neural bases for addictive properties of benzodiazepines.

Authors:  Kelly R Tan; Matthew Brown; Gwenaël Labouèbe; Cédric Yvon; Cyril Creton; Jean-Marc Fritschy; Uwe Rudolph; Christian Lüscher
Journal:  Nature       Date:  2010-02-11       Impact factor: 49.962

Review 10.  Nutritional and herbal supplements for anxiety and anxiety-related disorders: systematic review.

Authors:  Shaheen E Lakhan; Karen F Vieira
Journal:  Nutr J       Date:  2010-10-07       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.